GlassScriptPhysician profile
Douglas S Dow
NPI 1659371136
$7,249.46
in general payments reported to CMS, 2019-2025
42 companies · $1,404 in 2025
The $1,404 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $408 · 2021: $1,149 · 2022: $839 · 2023: $1,300 · 2024: $1,211 · 2025: $1,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,816 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,816.07 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,355.03 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Sumitomo Pharma America, INC. | $672.55 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $672.48 | 2019-2025 | Tria Firm, Rezum Generator, Lithoclast |
| Coloplast Corp | $505.27 | 2019-2025 | Altis |
| Agiliti Surgical, INC. | $400.44 | 2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Abbvie INC. | $357.90 | 2019-2025 | Lupron Depot, Botox |
| Procept Biorobotics Corporation | $351.76 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Janssen Biotech, INC. | $250.40 | 2019-2025 | Erleada |
| Angiodynamics, INC. | $241.69 | 2023-2024 | Nanoknife |
| Pfizer INC. | $204.43 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $179.63 | 2022-2025 | Pylarify |
| Olympus America INC. | $174.68 | 2020-2025 | Olympus, Itind System |
| Endo Pharmaceuticals INC. | $152.36 | 2019-2023 | Xiaflex, Aveed |
| Urovant Sciences INC | $146.40 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $121.86 | 2025 | Exparel |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $111.49 | 2019-2021 | |
| Healthtronics Stone Solutions, LLC | $105.96 | 2020-2022 | |
| Convatec INC. | $86.83 | 2019-2023 | |
| Ethicon US, LLC | $86.23 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $85.70 | 2024-2025 | Adstiladrin |
| Myovant Sciences INC. | $78.59 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $77.07 | 2025 | Trelstar, Tlando |
| Tolmar, INC. | $76.61 | 2024-2025 | Jatenzo, Eligard |
| Antares Pharma, INC. | $71.86 | 2019-2021 | |
| Axonics, INC. | $71.40 | 2020-2024 | Axonics |
| 180 Medical, INC. | $70.33 | 2019-2024 | Gentlecath |
| Laborie Medical Technologies Corp. | $66.80 | 2020-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Neotract INC. | $59.05 | 2019 | |
| Ambu INC. | $47.41 | 2022 | |
| Teleflex LLC | $45.76 | 2021-2022 | |
| Baxter Healthcare | $43.45 | 2024 | Perclot |
| Allergan, INC. | $42.88 | 2019-2020 | |
| Activ Surgical, INC. | $32.37 | 2022 | |
| Travere Therapeutics, INC. | $31.59 | 2019-2021 | |
| Davol INC. | $27.50 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.80 | 2025 | |
| Rgh Enterprises LLC | $22.49 | 2019 | |
| Urogen Pharma, INC. | $21.92 | 2024 | |
| Medtronic, INC. | $19.39 | 2022 | |
| Cook Medical LLC | $19.00 | 2024 | Ncircle |
| Clarus Therapeutics INC. | $18.01 | 2021 | |
| Acerus Pharmaceuticals Corporation | $17.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Dow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.